首页> 美国卫生研究院文献>Journal of Virology >Biochemical and Immunogenic Characterization of Soluble Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trimers Expressed by Semliki Forest Virus
【2h】

Biochemical and Immunogenic Characterization of Soluble Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trimers Expressed by Semliki Forest Virus

机译:Semliki森林病毒表达的可溶性人类免疫缺陷病毒1型信封糖蛋白三聚体的生化和免疫原性表征。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The current lack of envelope glycoprotein immunogens that elicit broadly neutralizing antibody responses remains a major challenge for human immunodeficiency virus type 1 (HIV-1) vaccine development. However, the recent design and construction of stable soluble gp140 trimers have shown that some neutralization breadth can be achieved by using immunogens that better mimic the functional viral spike complex. The use of genetic delivery systems to drive the in vivo expression of such immunogens for the stimulation of neutralizing antibodies against HIV-1 may offer advantages by maintaining the quaternary structure of the trimeric envelope glycoproteins. Here, we describe the biochemical and immunogenic properties of soluble HIV-1 envelope glycoprotein trimers expressed by recombinant Semliki Forest virus (rSFV). The results presented here demonstrate that rSFV supports the expression of stable soluble gp140 trimers that retain recognition by conformationally sensitive antibodies. Further, we show that rSFV particle immunizations efficiently primed immune responses as measured after a single boost with purified trimeric gp140 protein, resulting in a Th1-biased antibody response. This differed from the Th2-biased antibody response obtained after repeated immunizations with purified gp140 protein trimers. Despite this difference, both regimens stimulated neutralizing antibody responses of similar potency. This suggests that rSFV may be a useful component of a viral vector prime-protein boost regimen aimed at stimulating both cell-mediated immune responses and neutralizing antibodies against HIV-1.
机译:当前缺乏引起广泛中和抗体应答的包膜糖蛋白免疫原仍然是人类免疫缺陷病毒1型(HIV-1)疫苗开发的主要挑战。但是,稳定的可溶性gp140三聚体的最新设计和构建表明,使用更好地模拟功能性病毒刺突复合物的免疫原可以达到一定的中和广度。通过维持三聚体包膜糖蛋白的四级结构,使用基因递送系统来驱动此类免疫原的体内表达以刺激针对HIV-1的中和抗体可以提供优势。在这里,我们描述了由重组Semliki森林病毒(rSFV)表达的可溶性HIV-1包膜糖蛋白三聚体的生化和免疫原性。此处显示的结果表明,rSFV支持稳定的可溶性gp140三聚体的表达,该三聚体保留了构象敏感抗体的识别。此外,我们显示rSFV颗粒免疫有效地引发了免疫反应,如用纯化的三聚体gp140蛋白进行单次加强免疫后所测量的,导致了Th1偏向的抗体反应。这不同于用纯化的gp140蛋白三聚体重复免疫后获得的Th2抗体反应。尽管存在这种差异,但两种方案均刺激了具有相似效力的中和抗体反应。这表明rSFV可能是病毒载体初免蛋白加强方案的有用组成部分,旨在刺激细胞介导的免疫反应和中和针对HIV-1的抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号